drug discovery platform Archive

  • EMD Serono, Inc licensed Quantum Pharmaceuticals’ drug discovery technology.

    EMD Serono, Inc licensed Quantum Pharmaceuticals’ drug discovery technology.

    Moscow, 10 December, 2007 EMD Serono, Inc entered license agreement with Quantum Pharmaceuticals to get an access to Quantum Pharmaceuticals’ small molecule hit identification computational platform and apply it in in-house research. The Quantum Pharmaceuticals’ industry leading computational drug design technologies is based on applying...

    Full Story